keyword
https://read.qxmd.com/read/38462934/prevalence-and-characteristics-of-patients-prescribed-opioids-and-central-nervous-system-depression-agents-on-discharge-to-hospice-care
#21
JOURNAL ARTICLE
Cindy T Nguyen, Mary Lynn McPherson, Brie N Noble, Jon P Furuno
BACKGROUND: Hospice patients with end-stage liver disease (ESLD) have an increased risk of adverse drug events due to physiological changes and changes in pharmacokinetic and pharmacodynamic properties of medications; however, the use of opioid and central nervous system (CNS) depressant prescribing among patients with ESLD is prevalent. This study quantified the frequency and distribution of opioid and concomitant respiratory and CNS depressant prescribing among hospice patients with ESLD compared to other common hospice diagnoses of cancer, chronic obstructive pulmonary disorder (COPD), heart failure, and end-stage renal disease...
March 6, 2024: Annals of Palliative Medicine
https://read.qxmd.com/read/38462441/medical-economic-effect-of-pharmaceutical-interventions-by-board-certified-pharmacists-in-palliative-pharmacy-for-patients-with-cancer-using-medical-narcotics-in-japan-a-multicenter-retrospective-study
#22
JOURNAL ARTICLE
Takehiro Kawashiri, Hideki Sugawara, Katsuya Makihara, Rintaro Ohno, Yoshihiro Miyamoto, Noriaki Hidaka, Mayako Uchida, Hisamitsu Takase
BACKGROUND: The Japanese Society for Pharmaceutical Palliative Care and Sciences specializes in pharmacology in the field of palliative medicine. More than 700 board-certified pharmacists in palliative pharmacy (BCPPP) are actively involved in palliative pharmacotherapy at various hospitals and pharmacies. The purpose of this study was to determine the economic effect of pharmaceutical interventions by BCPPPs. METHODS: This multicenter retrospective study included 27 medical centers and analyzed the medical economic effect of interventions by BCPPPs (17 pharmacists) and non-BCPPPs (24 pharmacists) on patients using medical narcotics for cancer pain in September 2021...
2024: Journal of Nippon Medical School
https://read.qxmd.com/read/38456276/editor-s-note-effectiveness-and-safety-of-opioids-on-breathlessness-and-exercise-endurance-in-patients-with-chronic-obstructive-pulmonary-disease-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials
#23
https://read.qxmd.com/read/38453406/inpatient-deaths-by-medical-service-characteristics-in-a-comprehensive-cancer-centre
#24
JOURNAL ARTICLE
Sebastiano Mercadante, Alessio Lo Cascio, Alessandra Casuccio
AIM: To examine the intensity of care in the last 3 days of life in different medical settings of a comprehensive cancer centre. METHODS: In this retrospective study, the charts of patients who died in hospital from July 2019 to June 2023 were reviewed. The units taken into consideration were acute palliative care unit (APCU), oncology (ONC) and haematology (HEM), which included also the transplantation unit. Age, gender, diagnosis, Karnofsky or Eastern Cooperative Oncology Group, drugs used in the last 3 days of life, respiratory support, transfusion, parenteral nutrition, imaging studies, blood gas analysis, biochemistry, consultations and endoscopy were retrieved...
March 7, 2024: BMJ Supportive & Palliative Care
https://read.qxmd.com/read/38453203/state-level-variation-in-distribution-of-oxycodone-and-opioid-related-deaths-from-2000-to-2021-an-ecological-study-of-arcos-and-cdc-wonder-data-in-the-usa
#25
JOURNAL ARTICLE
Jay P Solgama, Edward Liu, Mellar Davis, Jove Graham, Kenneth L McCall, Brian J Piper
OBJECTIVES: This study aims to characterise oxycodone's distribution and opioid-related overdoses in the USA by state from 2000 to 2021. DESIGN: This is an observational study. SETTING: More than 80 000 Americans died of an opioid overdose in 2021 as the USA continues to struggle with an opioid crisis. Prescription opioids play a substantial role, introducing patients to opioids and providing a supply of drugs that can be redirected to those seeking to misuse them...
March 7, 2024: BMJ Open
https://read.qxmd.com/read/38452178/association-between-self-reported-pain-severity-and-characteristics-of-united-states-adults-age-%C3%A2-50-years-who-used-opioids
#26
JOURNAL ARTICLE
David R Axon, Oiza Aliu
OBJECTIVE: The aim of this study was to assess the associations between the characteristics of United States (US) adults (≥50 years) who used opioids and self-reported pain severity using a nationally representative dataset. METHODS: This retrospective cross-sectional database study used 2019 Medical Expenditure Panel Survey data to identify US adults aged ≥50 years with self-reported pain within the past 4 weeks and ≥1 opioid prescription within the calendar year ( n = 1,077)...
January 1, 2024: Scandinavian Journal of Pain
https://read.qxmd.com/read/38449833/attitudes-toward-social-issues-related-to-opioid-use-among-palliative-care-physicians
#27
JOURNAL ARTICLE
In Cheol Hwang, Seong Hoon Shin, Youn Seon Choi, Myung Ah Lee, DaeKyun Kim, Kyung Hee Lee
PURPOSE: This study investigated palliative care physicians' attitudes regarding social issues related to opioid use. METHODS: An email survey was sent to 674 physicians who were members of the Korean Society for Hospice and Palliative Care (KSHPC). RESULTS: Data from 66 physicians were analyzed (response rate, 9.8%). About 70% of participants stated that their prescribing patterns were not influenced by social issues related to opioid use, and 90% of participants thought that additional regulations should be limited to non-cancer pain...
March 1, 2024: J Hosp Palliat Care
https://read.qxmd.com/read/38429116/methadone-as-an-adjuvant-analgesic
#28
JOURNAL ARTICLE
Julita Shahab, Derek Willis
Methadone as an 'adjuvant' has proven to be effective and safe to be used in conjunction with opioids. Generally, only a low dose is required to improve pain control.
March 1, 2024: BMJ Supportive & Palliative Care
https://read.qxmd.com/read/38417963/investigating-the-efficacy-and-safety-of-olanzapine-prophylaxis-for-opioid-induced-nausea-and-vomiting-jortc-pal20-a-study-protocol-for-an-open-label-single-arm-exploratory-study
#29
JOURNAL ARTICLE
Eriko Satomi, Tomomi Kobayashi, Ayaka Ishikawa, Sayaka Arakawa, Hiroto Ishiki, Koji Amano, Naomi Sakiyama, Keisuke Ariyoshi, Kota Kihara, Shunsuke Oyamada, Akio Mizushima
INTRODUCTION: In opioid therapy for cancer pain, opioid-induced nausea and vomiting (OINV) occur in 20%-40% of patients during initial opioid treatment or increasing opioid doses. OINV result in failure to achieve pain relief due to poor opioid adherence. Therefore, antiemetics are used to prevent OINV, but their efficacy and safety in this context have not yet been fully elucidated. Olanzapine is a promising antiemetic for the prophylaxis of chemotherapy-induced nausea and vomiting. METHODS AND ANALYSIS: This single-arm, single-centre exploratory study will evaluate the prophylactic antiemetic efficacy and safety of 5 mg olanzapine in patients with cancer pain who are withholding initial regular opioid therapy...
February 27, 2024: BMJ Open
https://read.qxmd.com/read/38408794/opioid-toxicity-after-oxycodone-naloxone-to-oxycodone-conversion-case-series
#30
JOURNAL ARTICLE
Mairead Doherty, Hannah Joan Featherstone, Clare McAleer, Chloe Webb, Maeve O'Reilly, Marie Twomey, Regina McQuillan
Combination preparations of oxycodone/naloxone are marketed to aid in the management of opioid induced bowel dysfunction, with caution advised in prescribing in cases of liver dysfunction.This case series demonstrates four cases of patients with normal liver function tests who developed significant opioid toxicity on conversion from combination oxycodone/naloxone to oxycodone at equivalent doses, necessitating significant dose reduction.In each case, a cause for intra-hepatic shunting such as cirrhosis, porto-systemic collaterals or thrombosis were identified, highlighting these as cautionary features when prescribing combination preparations of oxycodone/naloxone and the possible need for dose reduction if converting to oxycodone...
February 26, 2024: BMJ Supportive & Palliative Care
https://read.qxmd.com/read/38386259/palliative-radiotherapy-for-painful-non-bone-lesions-in-patients-with-advanced-cancer-a-single-center-retrospective-study
#31
JOURNAL ARTICLE
Yurika Shindo, Yutaro Koide, Naoya Nagai, Tomoki Kitagawa, Takahiro Aoyama, Hidetoshi Shimizu, Shingo Hashimoto, Hiroyuki Tachibana, Takeshi Kodaira, Shunichi Ishihara, Shinji Naganawa
PURPOSE: This retrospective study aimed to assess the efficacy and safety of palliative radiotherapy for painful non-bone lesions in patients with advanced cancer. MATERIALS AND METHODS: We enrolled patients with painful non-bone lesions who underwent conventional palliative radiotherapy between September 2018 and September 2022. The treatment targets included primary tumor lesions, lymph node metastases, non-bone hematogenous metastases, and other lesions. The primary endpoint was the overall pain response rate in evaluable patients, determined based on the International Consensus Pain Response Endpoint criteria...
February 22, 2024: Japanese Journal of Radiology
https://read.qxmd.com/read/38378244/palliative-radiotherapy-survival-prognostic-factors-single-centre-retrospective-cohort-study
#32
JOURNAL ARTICLE
Sian Cooper, Mary Denholm, Abdul Shawal Malek, Jeffrey Arun Rubasingham, David Tsang
OBJECTIVE: Patients with non-curative malignancy can receive palliative radiotherapy (PR) to alleviate symptoms. However, choosing the right patient to receive PR can be challenging, as some patients may not survive long enough to gain benefit. This study aims to identify prognostic factors for overall survival (OS) and 30-day mortality (30DM) following PR and to test these in a real-world cohort. METHOD: A retrospectively collected data set of all adults completing PR between 1 August 2018 and 31 December 2018 at a single centre (n=214, Southend University Hospital NHS Foundation Trust, UK) was used to test prognostic factors...
February 20, 2024: BMJ Supportive & Palliative Care
https://read.qxmd.com/read/38375593/prevalence-of-abnormal-urine-drug-tests-during-covid-19-pandemic-in-the-cancer-patient-population-retrospective-study
#33
JOURNAL ARTICLE
Vishal Bansal, Loc Lam, Ashlyn Victoria Brown, Saba Javed
Background: Opioid misuse is a persistent concern, heightened by the COVID-19 pandemic. This study examines the risk factors contributing to elevated rates of abnormal urine drug tests (UDTs) in the cancer pain patient population during COVID-19. Materials & methods: A retrospective chart review of 500 patient encounters involving UDTs at a comprehensive cancer center. Results: Medication adherence rates increase when UDTs are incorporated into a chronic cancer pain management protocol. Higher positive tests for illicit or nonprescribed substances in patients with specific risk factors: current smokers (tobacco), no active cancer and concurrent benzodiazepine use...
February 20, 2024: Pain Management
https://read.qxmd.com/read/38373779/pain-management-and-the-use-of-opioids-in-adults-with-kidney-failure-receiving-conservative-kidney-management
#34
JOURNAL ARTICLE
Sara N Davison, Nicola Wearne, Peace Bagasha, Rene Krause
Conservative kidney management (CKM) is an active treatment for kidney failure (KF) for people who will either not benefit from kidney replacement therapy (KRT), do not wish to pursue KRT, or do not have access to KRT. CKM aims to improve patients' quality-of-life through meticulous attention to symptom management. KF is associated with a high symptom burden globally that is experienced across age, sex, and race with chronic pain being one of the most severe and common symptoms. The delivery of CKM therefore requires the integration of effective pain management strategies...
January 24, 2024: Annals of Palliative Medicine
https://read.qxmd.com/read/38365070/palliative-approach-remains-lacking-in-terminal-hospital-admissions-for-chronic-disease-across-rural-settings-multisite-retrospective-medical-record-audit
#35
JOURNAL ARTICLE
Assoc Prof Rebecca Disler, Dr Amy Pascoe, Dr Xinye Esther Chen, Emily Lawson, Michael Cahyadi, Ajanth Paalendra, Dr Helen Hickson, Prof Julian Wright, Bronwyn Phillips, Dr Sivakumar Subramaniam, Dr Kristen Glenister, Prof Jenny Philip, Prof Doranne Donesky, Assoc Prof Natasha Smallwood
INTRODUCTION/AIM: Despite clear benefit from palliative care in end-stage chronic diseases, access is often limited, and rural access largely undescribed. This study sought to determine if a palliative approach is provided to people with chronic disease in their terminal hospital admission. METHODS: Multisite, retrospective medical record audit, of decedents with a primary diagnosis of chronic lung, heart or renal failure, or multimorbidity of these conditions over 2019...
February 14, 2024: Journal of Pain and Symptom Management
https://read.qxmd.com/read/38361729/palliative-care-rounds-a-thanksgiving-break-to-discuss-rib-fractures
#36
Richard V Guthrie, Sharene Best, Ryan Baldeo, Jamie Ellis-Wittenhagen, Tyler Murphy
Rib fractures are common injuries, especially in the frail and elderly. They can happen in isolation or may be associated with significant concomitant morbidity, including but not limited to pain, pneumonia, or pneumothorax. In the palliative care population, rib fractures can be overlooked or attributed to other entities, which may lead to inappropriate treatment. The commonly accepted standards of care for the treatment of rib fractures are centered around early and adequate pain control, and stabilization of other complications...
January 2024: Curēus
https://read.qxmd.com/read/38350512/beyond-breathing-systematic-review-of-global-chronic-obstructive-pulmonary-disease-guidelines-for-pain-management
#37
REVIEW
Kaelee Brockway, Shakeel Ahmed
CONTEXT: Patients with chronic obstructive pulmonary disease (COPD) experience pain as both symptom and comorbidity. There has been no evaluation of the recommendations for pain management in updated clinical practice guidelines (CPGs). OBJECTIVES: Update the evidence on pain management, determine alignment of pain management recommendations with best-practice, and advocate for optimal pain management in patients with COPD. METHODS: PubMed, Guideline International Network, Guideline Portal, Agency for Healthcare Research and Quality, National Institute for Healthcare Excellence, Scottish International Guidelines Network, Institute of Medicine, grey literature, national websites, and bibliographies were searched...
February 11, 2024: Respiratory Medicine
https://read.qxmd.com/read/38341456/the-effects-of-oprm1-118a-g-on-methadone-response-in-pain-management-in-advanced-cancer-at-end-of-life
#38
REVIEW
Larisa M Haupt, Alison Haywood, Heidi G Sutherland, Chieh Yu, Cassie L Albury, Anushka Pharasi, Mathew Zunk, Rani George, Lyn R Griffiths, Phillip Good, Janet Hardy
Cancer pain is the most feared symptom at end of life. Methadone has advantages over other opioids but is associated with significant variability in clinical response, making dosing challenging in practice. OPRM1 is the most studied pharmacogene associated with the pharmacodynamics of opioids, however reports on the association of the A118G polymorphism on opioid dose requirements are conflicting, with no reports including methadone as the primary intervention. This association study on OPRM1 A118G and response to methadone for pain management, includes a review of this genetic factor's role in inter-patient variability...
February 10, 2024: Scientific Reports
https://read.qxmd.com/read/38339319/pain-catastrophizing-in-cancer-patients
#39
JOURNAL ARTICLE
Sebastiano Mercadante, Patrizia Ferrera, Alessio Lo Cascio, Alessandra Casuccio
BACKGROUND: Pain catastrophizing is a group of negative irrational cognitions in the context of anticipated or actual pain. The aim of this study was to decipher the possible role of catastrophism on pain expression and outcomes after a comprehensive palliative care treatment. METHODS: A consecutive sample of patients with uncontrolled pain was assessed. Demographic characteristics, symptom intensity included in the Edmonton symptom assessment system (ESAS), and opioid drugs used were recorded at admission (T0)...
January 29, 2024: Cancers
https://read.qxmd.com/read/38326740/perceptions-on-use-of-opioids-in-palliative-care-of-dyspnoea-in-patients-with-fibrotic-interstitial-lung-disease-and-chronic-obstructive-pulmonary-disease-a-qualitative-study
#40
JOURNAL ARTICLE
Camilla Yde Hvelplund, Birgit Refsgaard, Elisabeth Bendstrup
BACKGROUND: Many patients with chronic obstructive pulmonary disease and fibrotic interstitial lung disease suffer from severe dyspnea and reduced quality of life, despite receiving optimal disease-modifying treatment for their illness. Studies have suggested that these patients may benefit from treatment with low-dose opioids. However, many patients decline opioid treatment. This has led to patients not receiving proper palliative treatment of their lung disease. AIM: To identify potential barriers that prevent patients from receiving adequate palliative care with opioids and enable doctors to address patients' concerns...
February 7, 2024: American Journal of Hospice & Palliative Care
keyword
keyword
42886
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.